Skip to main content
Gabbard's Treatments of Psychiatric Disorders
Featured!

Gabbard's Treatments of Psychiatric Disorders, Fifth Edition

Edited by Glen O. Gabbard, M.D.
2014
1,247 pages
ISBN 978-1-58562-442-3
Hardcover
Item #62442



The definitive treatment textbook in psychiatry, this fifth edition of Gabbard's Treatments of Psychiatric Disorders has been thoroughly restructured to reflect the new DSM-5® categories, preserving its value as a state-of-the-art resource and increasing its utility in the field. The editors have produced a volume that is both comprehensive and concise, meeting the needs of clinicians who prefer a single, user-friendly volume. In the service of brevity, the book focuses on treatment over diagnostic considerations, and addresses both empirically-validated treatments and accumulated clinical wisdom where research is lacking.

Noteworthy features include the following:


  • Content is organized according to DSM-5® categories to make for rapid retrieval of relevant treatment information for the busy clinician.
  • Outcome studies and expert opinion are presented in an accessible way to help the clinician know what treatment to use for which disorder, and how to tailor the treatment to the patient.
  • Content is restricted to the major psychiatric conditions seen in clinical practice while leaving out less common conditions and those that have limited outcome research related to the disorder, resulting in a more streamlined and affordable text.
  • Chapters are meticulously referenced and include dozens of tables, figures, and other illustrative features that enhance comprehension and recall.

An authoritative resource for psychiatrists, psychologists, and psychiatric nurses, and an outstanding reference for students in the mental health professions, Gabbard's Treatments of Psychiatric Disorders, Fifth Edition, will prove indispensable to clinicians seeking to provide excellent care while transitioning to a DSM-5® world.

Contributors. Introduction. Part I: Neurodevelopmental Disorders and Elimination Disorders. Intellectual disability. Communication disorders. Autism spectrum disorder. Attention-deficit/hyperactivity disorder. Specific learning disorders. Tic disorders. Elimination disorders. Part II: Schizophrenia Spectrum and Other Psychotic Disorders. Early stage schizophrenia. Toward a dimensional understanding of psychosis and its treatment. Psychosocial treatments for chronic psychosis. Pharmacological treatment of psychosis. Part III: Bipolar and Related Disorders and Depressive Disorders. Psychotherapy of mood disorders. Acute and maintenance treatment of bipolar disorder and related disorders. Pharmacological and somatic treatments for major depressive disorder. Brain stimulation treatments for mood disorders. Part IV: Anxiety Disorders and Obsessive-Compulsive and Related Disorders. Panic disorder. Separation anxiety disorder. Social anxiety disorder. Generalized anxiety disorder. Specific phobias. Obsessive-compulsive disorder. Body dysmorphic disorder. Hoarding disorder, trichotillomania (hair-pulling disorder), and excoriation (skin-picking) disorder. Part V: Dissociative Disorders and Trauma- And Stressor-Related Disorders. Dissociative identity disorder. Depersonalization/derealization disorder. Dissociative amnesia. Posttraumatic stress disorder. Acute stress disorder. Adjustment disorders. Part VI: Somatic Symptom and Related Disorders and Eating Disorders. Evidence-based psychological treatments for eating disorders. Pharmacological treatment of eating disorders. Intensive treatment for eating disorders. Primary care and consultation-liaison interventions for somatic symptom and related disorders. Pharmacological interventions for psychosomatic disorders. Intensive interventions for somatic symptom disorders. Part VII: Sleep-Wake Disorders. Sleep disorders. Part VIII: Sexual Dysfunctions, Paraphilic Disorders, and Gender Dysphoria. Sexual dysfunctions. Paraphilias and paraphilic disorders. Gender dysphoria. Part IX: Disruptive, Impulse-Control, and Conduct Disorders. Oppositional defiant disorder. Intermittent explosive disorder. Conduct disorder. With limited prosocial emotions specifier for conduct disorder. Pyromania. Kleptomania. Part X: Substance-Related and Addictive Disorders. Alcohol-related disorders. Sedative-, hypnotic-, or anxiolytic-related disorders. Opioid-related disorders: opioid detoxification. Opioid-related disorders: antagonist treatment. Opioid-related disorders: agonist maintenance treatment. Hallucinogen-related disorders. Cannabis-related disorders. Club drug addiction. Stimulant-related disorders. Nicotine-related disorders. Individual therapy for substance use disorders. Cognitive, behavioral, and motivational therapies for substance use disorders. Group therapy for substance use disorders. Family therapy in substance abuse. Network therapy for substance use. Pain and addiction. Gambling disorder. Part XI: Neurocognitive Disorders. Delirium. Neurocognitive disorder due to Alzheimer’s disease. Frontotemporal neurocognitive disorder. Vascular neurocognitive disorder. Neurocognitive disorder due to Parkinson’s disease. Part XII: Personality Disorders. Paranoid, schizotypal, and schizoid personality disorders. Antisocial personality disorder. Borderline personality disorder. Histrionic personality disorder. Narcissistic personality disorder. Cluster C personality disorders: avoidant, dependent, and obsessive-compulsive. Index.
"This is an absolutely stellar collection of treatment reviews across the full spectrum of mental disorders. It beautifully complements the recently published DSM-5 by providing up-to-date summaries of evidence bearing upon the treatment and management of mental disorders. Its editor, Glen Gabbard, is a clinical scholar and teacher of immense stature who has shown exquisite judgment in his choice of authors for the reviews that comprise this fifth volume of the series he initiated. Dr. Gabbard has chosen many of the world’s best clinician-scientists to prepare these chapters. The net effect is a first rate bridging of science and service. Kudos, and thanks, to Dr. Gabbard for the legacy he has created."—Charles F. Reynolds III M.D., University of Pittsburgh School of Medicine, Director, UPMC/Pitt Aging Institute
Laura N. Antar, M.D., Ph.D.
David B. Arciniegas, M.D.
Evelyn Attia, M.D.
Richard Balon, M.D.
E. Baron Short, M.D., M.S.C.R.
Joseph H. Beitchman, M.D.
Silvia Bernardi, M.D.
Carlos Blanco, M.D., Ph.D.
Michael H. Bloch, M.D.
John Bradford, M.B.Ch.B.
Bethany Brand, Ph.D.
Laura C. Bruce, M.A.
Richard A. Bryant, Ph.D.
Laura Campbell-Sills, Ph.D.
Kenneth M. Carpenter, Ph.D.
S. Charles Schulz, MD
Lois Choi-Kain, M.D.
J. Christopher Perry, M.D.
Domenic A. Ciraulo, M.D.
Anita Clayton, M.D.
Emil F. Coccaro, M.D.
Kathryn A. Cunningham, Ph.D.
Jill Cyranowski, Ph.D.
Itai Danovitch, M.D.
Christina Delos Reyes, M.D.
Joel E. Dimsdale, M.D.
Karl Doghramji, M.D.
Michael E.Thase, M.D.
Shaun M. Eack, Ph.D.
Brian A. Fallon, M.D., M.P.H.
Robert L. Findling, M.D., M.B.A.
Ariadna Forray, M.D.
Ellen Frank, Ph.D.
Matthew J. Friedman
Leah D. Fryml
Glen O. Gabbard, M.D.
Marc Galanter, M.D.
Mark S. George, M.D.
Ted Avi Gerstenblith, M.D.
Danielle Goerke, D.O.
Joseph F. Goldberg, M.D.
Jon E. Grant, J.D., M.D., M.P.H.
Kevin M. Gray, M.D.
John H. Greist, M.D.
John G. Gunderson, M.D.
James C. Harris, M.D.
Richard G. Heimberg, Ph.D.
Eric Hollander, M.D.
Anna M. Homen, M.A.
Anna Ivanenko M.D., Ph.D.
Elena I. Ivleva, M.D., Ph.D.
Nicholas C. Jacobson, M.S.
Ms. Jacqui Lingler
Kelli Jane Kerr Harding, M.D.
Philip G. Janicak, M.D.
Suzanne G. Jasberg, M.D.
James W. Jefferson, M.D.
Allan S. Kaplan, M.D.
Kathryn A. Keegan, M.D
Meredith A. Kelly, M.D.
Geoffrey A. Kerchner, M.D., Ph.D.
Matcheri S. Keshavan, M.D.
Terence A. Ketter, M.D.
Eve Khlyavich Freidl, M.D.
Eva R. Kimonis, Ph.D.
Robert A. King, M.D.
Herbert D. Kleber, M.D.
Nastassja Koen, M.B.Ch.B.
Ruth A. Lanius, M.D., Ph.D.
Anne A. Lawrence, M.D., Ph.D.
James F. Leckman, M.D.
Frances R. Levin, M.D.
Joshua D. Lipsitz, Ph.D.
Sandra J. Llera, Ph.D.
Richard J. Loewenstein, M.D.
Constantine G. Lyketsos, M.D., M.H.S.
Candice Maietti
Jos� R. Maldonado, M.D.
Christopher Marano, M.D.
Marsha Marcus, Ph.D.
John J. Mariani, M.D.
Carla Marienfeld, M.D.
Laura Marsh, M.D.
Laurel ES. Mayer M.D.
Lindsay A. Mays, M.A.
Robert J. McMahon, Ph.D.
Molly McVoy, M.D.
David J. Miklowitz, Ph.D.
Shefali Miller, M.D.
Barbara Milrod, M.D.
James E. Mitchell, M.D.
Daniel J. Moran, Ph.D.
Lisa Murphy, M.C.A.
Michelle G. Newman, Ph.D.
Mark J. Niciu, M.D., Ph.D.
Ginger E. Nicol, M.D.
Ginger E. Nicol, MD
Edward V. Nunes, M.D.
Michael B. O�Sullivan, M.D.
Dustin A. Pardini, M.D.
Dave S. Pasalich, Ph.D.
J. Paul Fedoroff, M.D.
Robert N. Pechnick, Ph.D.
Christopher Pelic, M.D.
Katharine A. Phillips, M.D.
Peter V. Rabins, M.D., M.P.H.
J. Reid Meloy, Ph.D.
William G. Reiner, MD
Daniel Richter M.D.
James L. Roerig, Pharm.D., B.C.P.P.
Gustavo C. Rom�n, M.D.
Elsa F. Ronningstam, Ph.D.
Michael H. Rosenbloom, M.D.
Barbara O. Rothbaum
Anthony J. Rothschild, M.D.
Franklin Schneier, M.D.
Sidney Schnoll, M.D., Ph.D.
Richard S. Schottenfeld, M.D.
Richard C. Shelton, M.D.
Bryna Siegel, Ph.D.
Daphne Simeon, M.D.
Courtney M. Sinclair
Jonathan Snipes, M.D.
Mehmet Sofuoglu, M.D., Ph.D.
David Spiegel, M.D.
Jason Spivey, M.D.
Kristine J. Steffen, Pharm.D., Ph.D.
Murray B. Stein, M.D., M.P.H.
Dan J. Stein, F.R.C.P.C., Ph.D.
Peter Steinglass, M.D.
Theodore A. Stern, M.D.
Michael H. Stone, M.D.
Griffin A. Stout, MD
Denis G. Sukhodolsky, Ph.D.
Maria Sullivan, M.D., Ph.D.
Holly A. Swartz, M.D.
Lauren E. Szkodny, M.S.
Carol A. Tamminga, M.D.
Joseph J. Taylor
Arnold M. Washton, Ph.D.
Michael Weaver, M.D.
Igor Weinberg, Ph.D.
Sharon B. Wigal, Ph.D.
Jennifer E. Wildes, Ph.D.
George E. Woody, M.D.
Lawson Wulsin, M.D.
Jessica Yakeley, F.R.C.
Calvin T. Yang, M.D., Ph.D.
Michele York, Ph.D.
Arlene R. Young, Ph.D.
Cole Youngner, B.A.
Carlos A. Zarate, Jr., M.D.
Glen O. Gabbard, M.D., is Clinical Professor of Psychiatry at Baylor College of Medicine in Houston, Texas and Professor of Psychiatry at State University of New York in Syracuse. He is also Training and Supervising Analyst at the Center for Psychoanalytic Studies in Houston.
List Price $199.00
APA Member Price $159.20
APA Resident-Fellow Member Price $149.25
Ordering from Europe? Click Here